TriSalus Life Sciences (TLSI) Return on Capital Employed (2021 - 2026)

TriSalus Life Sciences (TLSI) has 6 years of Return on Capital Employed data on file, last reported at 67.75% in Q1 2026.

• For the quarter ending Q1 2026, Return on Capital Employed rose 15103.0% year-over-year to 67.75%; the trailing twelve-month figure through Mar 2026 stood at 67.75% (up 15103.0% YoY), and the FY2025 full-year result was 148.45%, up 10884.0% from the prior year.
• Return on Capital Employed for Q1 2026 stood at 67.75%, up from 110.44% in the prior quarter.
• Across five years, Return on Capital Employed topped out at 1.17% in Q2 2022 and bottomed at 817.14% in Q1 2024.
• The 5-year median for Return on Capital Employed is 182.56% (2023), against an average of 215.54%.
• The widest annual swing landed in 2024, when Return on Capital Employed tumbled 63458 bps; it then jumped 59836 bps in 2025.
• A 5-year view of Return on Capital Employed shows it stood at 19.98% in 2022, then slumped by 1793 bps to 378.2% in 2023, then surged by 38 bps to 233.38% in 2024, then surged by 53 bps to 110.44% in 2025, then soared by 39 bps to 67.75% in 2026.
• The last three Return on Capital Employed figures came in at 67.75% (Q1 2026), 110.44% (Q4 2025), and 111.7% (Q3 2025), per Business Quant data.

Peer Comparison